[摘 要] 目的：探讨参芪片在甲亢(Graves病)患者中的临床疗效。方法：选取我院2000年1月至2004年9月62例Graves病患者，随机分入常规治疗组(A组，31例)和参芪片治疗组(B组，31例)。B组在常规口服药物治疗的基础上加用参芪片，每次2片，每天3次。在入组前以及服药每周内门诊随访，行血常规检查，共4周。结果：62例患者全部完成随访。A组中6例出现白细胞减少，1例出现粒细胞减少症，停用抗甲状腺药物治疗，而B组2例出现白细胞减少，无粒细胞减少症发生，两组相比有统计学意义(P<0.05)。结论：在常规药物治疗的基础上联用参芪片，可以使Graves病患者副作用减少，但确切的效果有待于大规模的随机对照试验来评价。

    [关键词] Graves病；参芪片；粒细胞减少症

    Clinical Effect of Shenqipian in Patients with Graves Disease

    HU Biao

    (Chaoyang People's Hospital of Shantou， Shantou, Guangdong 515100，China)

    Abstract:Objective To evaluate the therapeutic efficacy of shenqipian in patients with Graves disease.Methods A total of 62 patients with graves disease were divided into two groups randomly：traditional medition therapy group(A) and shenqipian therapy group(B)from January 2000 to September 2004.Patients in B group were received a stabilization ......